Eli Lilly Collaborates With Rznomics On Hearing Loss Treatment In $1.3 Billion Pact

benzinga.com/25/05/45450675/eli-lilly-collaborates-with-south-korea-based-rznomics-for-rna-editing-therapies-for-hearing-loss-treatment-in-ov

Eli Lilly And Co (NYSE:LLY) on Thursday entered into a strategic global research collaboration and licensing agreement with Rznomics Inc., a South Korea-based biopharmaceutical company specializing in RNA-based therapeutics.
The agreement focuses on developing and commercializing…

This story appeared on benzinga.com, 2025-05-15 19:59:30.
The Entire Business World on a Single Page. Free to Use →